Type 2 Diabetes
Conditions
Brief summary
This study aims to test a dietary intervention for diabetes in a medical practice setting, with the aim of developing a model for diabetes care that can be used widely. The investigators hypothesize that a low-fat vegan diet will be effective for management of diabetes and will be feasible in a practice-based setting.
Detailed description
Specific Aim 1 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) improves glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in a within-group analysis. Specific Aim 2 tests the hypothesis that the nutrition intervention (low fat, low-GI vegan diet) is more effective than standard nutrition care for improving glycemic control, body weight, plasma lipid concentrations, blood pressure, and indices of renal function in individuals with type 2 diabetes Specific Aim 3 tests the hypothesis that a low-fat vegan diet is sustainable among individuals with type 2 diabetes for a 20-week period, with weekly classes, and in a follow-up period of one year with limited professional support. Specific Aim 4 tests the hypothesis that a low-fat vegan diet has an acceptability that is comparable to that of standard nutrition care among individuals with type 2 diabetes. Specific Aim 5 tests the hypothesis that the effects of the dietary interventions on A1c and body weight are reduced in individuals with the A1 allele of the Taq1A and Taq1B polymorphism
Interventions
OTHERvegan diet
Intervention group participants will follow a low-fat vegan diet and will receive instruction on this diet through the course of the study
OTHERdiet following ADA guidelines
participants will be given instruction on the ADA guidelines for diabetes, and will follow an individualized plan based on these guidelines
Sponsors
Physicians Committee for Responsible Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Caregiver)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. a diagnosis of type 2 diabetes mellitus, as defined by a fasting plasma glucose concentration ≥126 mg/dl on 2 occasions or a prior physician's diagnosis of type 2 diabetes with the use of hypoglycemic medications for at least 6 months 2. male or female 3. A1c between 6.5% and 10.5% 4. age at least 18 years 5. ability and willingness to participate in all components of the study 6. willingness to be assigned to either a low-fat, vegan diet or to standard nutrition care 7. diabetes medications unchanged for 1 month prior to volunteering for the study 8. patient of Dr. Mark Sklar
Exclusion criteria
1. body mass index \>45 kg/m2 2. alcohol consumption of more than 2 drinks per day or the equivalent, episodic increased drinking (e.g., more than 2 drinks per day on weekends), or a history of alcohol abuse or dependency followed by any current use 3. use of recreational drugs in the past 6 months (past drug use, if fully recovered, is not a criteria for exclusion) 4. pregnancy or plans to become pregnant 5. history of severe mental illness (with current unstable status) 6. likely to be disruptive in group sessions (as determined by research staff) 7. Signs/symptoms of acute uncontrolled diabetes (including but not limited to polyuria, polydipsia, blurred vision, uncontrolled weight loss) 8. unstable medical status 9. already following a low-fat, vegetarian diet 10. an inordinate fear of blood draws 11. inability to maintain current medication regimen 12. lack of English fluency
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hemoglobin A1C (diabetes management) | assessment at baseline (0 weeks) |
| lipid profile (serum cholesterol--total, LDL, HDL; triglycerides) | assessment at baseline (0 weeks) |
| body weight | assessment at baseline (0 weeks) |
| indices of renal function (serum creatinine, microalbumin) | assessment at baseline (0 weeks) |
Outcome results
None listed